AIM-HI Accelerator Fund shared a post on LinkedIn:
“We are proud to share that Dr. Sujuan Ba, CEO and Co-Founder of AIM-HI and President and CEO of the National Foundation for Cancer Research (NFCR), will speak at Excellentium 2026, hosted by Global Biotech Revolution.
Dr. Ba will join the panel ‘Building and Motivating Teams to Deliver Impact’, moderated by Elisabeth Guy-Dubois, along with Dr. Alexandra Zemp, Olivier Soula, Dr. Ruth R. Shah and Nigel Sheail. The discussion will explore how leaders can build and motivate teams, make strategic decisions, and lead for impact while empowering the next generation of biotech, life sciences, and healthcare leaders.
Through our annual AIM-HI Venture Competitions and other programs, AIM-HI supports scientist-entrepreneurs working to advance innovative cancer therapies and technologies. By helping early-stage oncology innovators strengthen their strategy, build connections, and access critical resources, AIM-HI works to bridge the gap between research breakthroughs and real-world patient impact.
Learn more about Excellentium 2026.
Learn more about AIM-HI’s work to support early-stage oncology innovators.”
Other articles about AIM-HI Accelerator Fund on OncoDaily.